Following SARS-CoV-2 infection, TLR4 activation on platelets may be associated with thrombotic events (such as myocardial infarction) in COVID-19 patients, and this thrombosis may affect the kidneys through cardio-renal syndrome. The gene discussed is TLR4; the disease is COVID-19.